semaglutide and estrogen Do GLP-1s work differently in women — and does menopause blunt their effect? Semaglutide and Menopause Weight Loss:

Incidence of hypoglycemia in selected placebo-controlled studies with GLP-1 receptor agonists combined with sulphonylureas

3 Although several factors contributed to this rise in interest, two key developments have been particularly important: Celebrity endorsement: A number of high-profile celebrities, such as Elon Musk, have publicly credited GLP-1RA drugs with their transformative weight loss, leading to a spike in public interest in using the drugs for weight loss

During the first three months of semaglutide therapy, thyroid labs should typically be rechecked at 6-8 week intervals, then every 3 months once stable on a maintenance dose

A systematic review also highlights psychological mechanisms associated with weight stability: autonomous motivation, self-efficacy, flexible restraint, and positive body image were all linked to improved outcomes, although the methodological quality of mediation analyses varies across studies [120]